Werner Sean 4
4 · BIOLIFE SOLUTIONS INC · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Werner Sean
Chief Technology Officer
Transactions
- Award
Common Stock
2025-03-18+22,919→ 27,784 total
Footnotes (1)
- [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation.